The Cardiac Effects of Prolonged Hypothermia After Cardiac Arrest

Cardiac Arrest Clinical Trial

Official title:

The Cardiac Effects of Prolonged Hypothermia After Cardiac Arrest

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02066753
• Other study ID #: TTH48AG
• Status: Completed
• Phase: N/A
• First received: February 17, 2014
• Last updated: November 24, 2015
• Start date: February 2013
• Est. completion date: November 2015

Study information

• Verified date: November 2015
• Source: University of Aarhus
• Contact: n/a
• Is FDA regulated: No
• Health authority: Denmark: The Regional Committee on Biomedical Research Ethics
• Study type: Interventional

Clinical Trial Summary

This PhD study is a sub study in a randomized clinical controlled multicenter trial named "TTH48" (ClinicalTrials.gov Identifier: NCT01689077).

The TTH48 trial examines prolonged mild therapeutic hypothermia ("MTH") at 32-34°C in 24 versus 48 hours with the primary outcome Cerebral Performance Category after 6 month in comatose out-of-hospital cardiac arrest patients.

THE OVERALL AIM OF THIS PhD STUDY IS TO INVESTIGATE THE CARDIAC FUNCTION AND THE HEMODYNAMICS BY BIOCHEMICAL CARDIAC MARKERS, ECHOCARDIOGRAPHY, BY ANALYZING THE USAGE OF INOTROPES/VASOPRESSORS AND BY ANALYZING ECG DATA FOR ARRHYTHMIAS IN THE 24 VERSUS 48 HOURS MTH GROUPS.

Description:

The PhD-study contains 3 sub studies:

• Study 1 estimates the extend of myocardial damage resulting from the primary arrest and from the reperfusion injuries: Area under the curve of cTnT and CK-MB as 12 repeated measurements and NT-proBNP as 4 measurements post arrest

-Hypothesis: There is a statistically significantly greater release of the cardiac biomarkers cTnT and NT-proBNP quantified by the area under the curve in the 24 versus the 48 hours group in the intervention period from 24 to 72 hours.

• Study 2 investigates MTH´s influence on systolic and diastolic function by standard and Tissue Doppler (TDI) echocardiography after 24, 48 and 72 hours. The primary endpoint is mitral annular systolic velocity ("S´ max")

-Primary hypothesis: There is statistically significant improvement in S' max from the time T24 to T72 in the 48 versus the 24 hours group.

-Secondary hypothesis: There is statistically significantly better systolic function at T48 measured in terms of individual S' max-change in the 48 hours group (still hypothermic) versus the 24 hours group (reached normothermia).

• Study 3 investigates MTH´s influence on the need for vasopressor or inotrope and the duration of arrhythmias during the first 72 hours post arrest.

• Primary hypothesis: There is a statistically significantly increased tendency of arrhythmias in the 48 versus the 24 hours group measured in the period from T0 to T72.

• Secondary hypothesis: There is a statistically significantly reduced need for inotropes in the 48 versus the 24 hours group measured by cumulative vasopressor index in the period from T0 to T72.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: November 2015
• Est. primary completion date: November 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

1. Resuscitated after cardiac arrest outside hospital with suspected cardiac triggering cause (and stabile circulation for at least 20 minutes after return of spontaneous circulation,

2. Glasgow coma score < 8 and

3. Age = 18 years and < 80 years.

Exclusion Criteria:

1. Cardiac arrest of suspected non-cardiac triggering cause (e.g. trauma, aortic dissection, massive bleeding, hypoxia or accidental hypothermia),

2. >60 minutes from cardiac arrest to ROSC,

3. Time from cardiac arrest until start of cooling >4 hours,

4. Terminal illness,

5. Coagulopathy (medical anticoagulation treatment including thrombolysis is not a contraindication),

6. Unwitnessed arrests with asystolia as presenting rhythm,

7. Pregnancy,

8. Persistent cardiogenic shock,

9. Systolic blood pressure <80 mmHg despite vasoactive treatment and intra-aortic balloon pump

10. CPC 3-4 before the cardiac arrest,

11. Suspected/confirmed acute intra cerebral hemorrhage or stroke,

12. Acute CABG or other operation in connection with performing CPR,

13. Lack of consent from the relatives,

14. Lack of consent from the GP and

15. Lack of consent from the patient if he/she wakes up and is relevant.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Cardiac Arrest
• Heart Arrest
• Hypothermia

Intervention

Procedure:
• Mild therapeutic hypothermia
Mild therapeutic hypothermia with a target temperature between 32-34°C.

Locations

Country	Name	City	State
Denmark	Department of Anesthesiology and Intensive Care Medicine, Aarhus University Hospital, Skejby	Aarhus N	Central Denmark Region
Norway	Research Center of Emergency Medicine and Department of Anesthesiology and Intensive Care Medicine, Stavanger University Hospital	Stavanger

Sponsors (1)

Lead Sponsor	Collaborator
University of Aarhus

Countries where clinical trial is conducted

Denmark,  Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Area under the curve cTnT	Allocated sub study 1	In the intervention period from 24 to 72 hours	No
Primary	Mitral annular systolic velocity	Allocated sub study 2	After 24 hours, 48 hours and 72 hours	No
Primary	Duration of arrhythmias	Allocated sub study 3	From target temperature (32-34°C) has been reached until 72 hours after	Yes
Primary	Cumulative vasopressor index	Allocated sub study 3	From target temperature (32-34°C) has been reached until 72 hours after	No
Secondary	Area under the curve NT-proBNP	Allocated sub study 1	In the intervention period from 24 to 72 hours	No

External Links

•   Link to the parent trial: TTH48